Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase II Study of Savolitinib in Subjects with MET Amplified Metastatic Colorectal Cancer
Phase II Study in Patients With Resected, Stage II High Risk and Stage III Colorectal Cancer
A Phase II, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS or NRAS Mutation
Study Type: Treatment
Phase: II
NCTID: NCT06106308
Principal Investigator:
Anup Kasi
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Study Type: Prevention
Phase: N/A
NCTID: NCT03100461
Principal Investigator:
Keith Allen Greiner JR
A Phase II Trial of Perioperative CV301 Vaccination in Combination with Nivolumab and and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer
Study Type: Treatment
Phase: II
NCTID: NCT03547999
Principal Investigator:
Anup Kasi
Omega 3 Fatty Acids in Colorectal Cancer CRC Prevention in Patients with Lynch Syndrome COLYNE
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT03831698
Principal Investigator:
Anwaar Saeed
Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy COMMIT Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair dMMR/Microsatellite Instability-High MSI-H Metastatic Colorectal Cancer
A Phase II/III Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT05141721
Principal Investigator:
Anup Kasi